Diabetes Res Clin Pract. 2020;168:108372. doi: 10.1016/j.diabres.2020.108372
Here, the Italian Society for Pediatric Endocrinology and Diabetology carried out a literature search in Medline and Embase and also Diabetes Societies websites until May 21st, 2020 for guidelines and recommendations on T1D management during the COVID-19 pandemic. They state that there is currently no evidence to suggest a higher risk of COVID-19 infection in children with diabetes than in unaffected peers. In addition, contrary to adult patients with diabetes, there are no reports suggesting that diabetes is associated with poor outcomes of COVID-19 infection in children and adolescents.
Many learned scientific societies have reacted to the COVID-19 pandemic swiftly and have issued standard operational procedures on how to manage diseases and best utilize medical services during the pandemic and/or lockdown periods. Despite the potential risk that the COVID-19 infection may develop into a more severe form in people with diabetes including children, this risk is considered to be very low when diabetes is well-controlled. However, several practical recommendations are made: children and adolescents affected by T1D, and/or by other chronic conditions, need uninterrupted access to insulin, drugs, supplies, such as insulin pumps, pens and syringes and technology and continuous specialist medical care, especially in stressful situations. Since the lockdown had actually reduced the access to outpatient clinics, many Italian pediatric diabetologists had rescheduled all routine checks as telephone and video-link consultations during the peak pandemic and lockdown periods. It seems that these measures helped to keep children and adolescents with diabetes in good metabolic control and to prevent an increase in acute or chronic adverse events.